Last reviewed · How we verify
NCT03273751
The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy
NA trial testing Remote Ischemic Preconditioning in Renal Neoplasm in 86 participants. Completed in 28 August 2018.
28 August 2018
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 86 |
| Start date | 1 September 2017 |
| Primary completion | 28 August 2018 |
| Estimated completion | 28 August 2018 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Remote Ischemic Preconditioning
- Sham control — full drug profile →
Conditions studied
- Renal Neoplasm — all drugs for Renal Neoplasm →
- Renal Injury — all drugs for Renal Injury →
Sponsor
Seoul National University Hospital
Who can join
20 and older, any sex, with Renal Neoplasm or Renal Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is intended to evaluate the renal protective effect of Remote Ischemic Preconditioning (RIPC) in patients undergoing partial nephrectomy. Half of the enrolled subjects will receive 4 cycles of brief ischemia on the upper arm after anesthesia induction and prior to the surgery, while the other half will not receive this treatment as a control group.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Perioperative Acute Kidney Injury.
Gumbert SD, Kork F, Jackson ML, Vanga N, et al · · 2020 · cited 209× · PMID 31687986 · DOI 10.1097/aln.0000000000002968 -
The Effect of Remote Ischemic Preconditioning on Serum Creatinine in Patients Undergoing Partial Nephrectomy: A Randomized Controlled Trial.
Chung J, Hur M, Cho H, Bae J, et al · · 2021 · cited 14× · PMID 33921503 · DOI 10.3390/jcm10081636 -
The effect of remote ischemic preconditioning on serum creatinine in patients undergoing partial nephrectomy: a study protocol for a randomized controlled trial.
Hur M, Park SK, Shin J, Choi JY, et al · · 2018 · cited 3× · PMID 30180887 · DOI 10.1186/s13063-018-2820-3
Verify or expand the search:
- PubMed search for NCT03273751
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Remote Ischemic Preconditioning
Trials testing the same drug.
- NCT06977230 — Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG · NA · recruiting
- NCT05147831 — Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Unde · NA · recruiting
- NCT05082207 — Ischemic Preconditioning and Thiol-disulfide Balance · NA · completed
- NCT03853473 — Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning · NA · completed
- NCT04174261 — Ticagrelor in Remote Ischemic Preconditioning Study · Phase 4 · completed
Other recruiting trials for Renal Neoplasm
Currently open trials in the same condition.
- NCT07227415 — Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica · Phase 1, PHASE2 · recruiting
- NCT06501079 — Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilater · NA · recruiting
- NCT05842044 — NSAID Use After Robotic Partial Nephrectomy · Phase 2 · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03273751 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 21 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03273751.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing